Westlake Pharmaceuticals (Hangzhou) Co., Ltd.
PrivateLast Round
Series B
Feb 20, 2024
Company Overview
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series B round in February 2024.
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. is a biotechnology company that develops first-in-class small molecule drugs for oncology and infectious diseases using an AI-driven drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. Comparables
Compare Westlake Pharmaceuticals (Hangzhou) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindRank | 85% | |
| Genesis Therapeutics | 84% | |
| Accutar Biotechnology | 82% |
For institutional investors. Book with your work email.
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 20, 2024 | ||||
| Series A | Nov 1, 2022 | ||||
| Angel | Dec 1, 2020 |
For institutional investors. Book with your work email.
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CAS Star | Angel |
| Zhejiang Financial Holding | Series B |
| HongShan Capital Group (HSG) | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2024
Raised Series B round with Zhejiang Financial Holding.
- Nov 1, 2022
Completed a Series A funding round.
For institutional investors. Book with your work email.
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Westlake Pharmaceuticals (Hangzhou) Co., Ltd.'s valuation, stock price, and market status.
Is Westlake Pharmaceuticals (Hangzhou) Co., Ltd. a public or private company?
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. is a private company.
What is the current stock price of Westlake Pharmaceuticals (Hangzhou) Co., Ltd.?
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Westlake Pharmaceuticals (Hangzhou) Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Westlake Pharmaceuticals (Hangzhou) Co., Ltd. worth (valuation)?
Valuation information for Westlake Pharmaceuticals (Hangzhou) Co., Ltd. is not publicly available.
Can I buy Westlake Pharmaceuticals (Hangzhou) Co., Ltd. stock?
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Westlake Pharmaceuticals (Hangzhou) Co., Ltd.'s last funding round?
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.'s most recent funding round was Series B on February 20, 2024.
Who are the main investors in Westlake Pharmaceuticals (Hangzhou) Co., Ltd.?
Key investors in Westlake Pharmaceuticals (Hangzhou) Co., Ltd. include CAS Star, Zhejiang Financial Holding, HongShan Capital Group (HSG).
Will Westlake Pharmaceuticals (Hangzhou) Co., Ltd. IPO soon?
No public IPO plans have been announced for Westlake Pharmaceuticals (Hangzhou) Co., Ltd..
How can I track Westlake Pharmaceuticals (Hangzhou) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Westlake Pharmaceuticals (Hangzhou) Co., Ltd.'s shares on secondary markets.